Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Conference on Instrumentations and Biotechnologies 2012

12 Nov 2012 - 14 Nov 2012 - Shanghai Everbright International Hotel



Bookmark and Share


Mission

CIB promotes scientific communication between academics and companies with interests in biotechnologies and instrumentations.

CIB Objectives

Create a platform and an opportunity for scientists, clinicians and researchers to communicate about topics in advanced biotechnologies and instrumentations for application to clinical research.
Act as a bridge between academics and companies to understand the development of advanced biotechnologies instrumentations, and their potential for commercialization and clinical application.
Strengthen and enhance academic dialogue and information exchange between biotechnology companies, industries and manufacturers, thereby facilitating the development of collaborative projects or partnerships.

Discuss the use of new instrumentations and devices in clinical practice and feed back experience of the instrumentations and devices to the manufacturers

Focuses

1.    Cyto-pharmacology, metabolism, efficacy and survival
2.    The use of clinical proteomic technologies, tissue imaging proteomics, antibody microarray and biomarkers for diagnosis, therapy and prognosis of disease
3.    Clinical gene microarray technologies in diagnosis of disease
4.    Cellular mathematics, biophysics, bioinformatics and computational biology
5.    Functional and molecular imaging, cellular imaging, tissue imaging and in vivo imaging
6.    Flow cytometry, cellomics, metabomics, and stem cell biology
7.    Organ functional measurements
8.    Laser capture microdissection, molecular pathologies, tissue microarray, digital imaging analysis and morphometric systems
9.    Experimental magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), thermography, and ultrasound imaging technologies
10.   Tissue bioengineering technologies

Audience and participants

Scientists, clinicians, researchers and students from universities, institutes, hospitals, and companies working on medical biotechnologies and instrumentations.



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Uncovering Rhinovirus C Structure
Researchers have determined the structure of rhinovirus C. Their findings may aid the development of antiviral therapies and vaccines.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Researchers Can Control Genes Involved in Cancer
A new way to control the activity of a protein, that is often upregulated in cancer, has been discovered by Moffitt researchers through monoubiquitination mechanism.
Mitochondrial Role in Metastatic Cancer
Researchers have manipulated proteins, sourced from tumour cells, that are essential for maintaining tumour cells and in doing so, have significantly reduced the ability of cancer cells.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!